Partnership for Health Analytic Research

Recent papers from Partnership for Health Analytic Research

1. Evaluate or Ignore: National Variation in the Evaluation of Adrenal Lesions in Over 250,000 PatientsSurgery · 2026
2. Effectiveness of teriflunomide in patients with relapsing multiple sclerosis who switched from other disease-modifying therapiesMedicine · 2025
3. Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non–Small Cell Lung CancerJCO Precision Oncology · 2025
4. Osilodrostat Treatment of Cushing Syndrome in Real-World Clinical Practice: Findings From the ILLUSTRATE studyJournal of the Endocrine Society · 2025
5. Healthcare Resource Utilization and Economic Burden of Prurigo Nodularis in the United StatesDermatology and Therapy · 2025
6. Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel studyESMO Gastrointestinal Oncology · 2025
7. A descriptive survey of patient experiences and access to specialty medicines with alternative funding programs2024
8. Development and validation of a claims-based algorithm to identify patients with Neuromyelitis Optica Spectrum disorderJournal of the Neurological Sciences · 2024
9. Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early DetectionCancer Discovery · 2024
10. Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination TherapyEuropean Urology Oncology · 2024
11. Modified Delphi panel consensus recommendations for management of severe aplastic anemiaBlood Advances · 2024
12. Understanding the Burden of Illness in People with Nonrelapsing Secondary Progressive Multiple Sclerosis in the United States: A Matched-cohort Study (P8-6.013)Neurology · 2024
13. Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuriaHematology · 2024
14. Value of next generation sequencing (NGS) testing in advanced cancer patientsJournal of Medical Economics · 2024
15. Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antiviralsJournal of Medical Economics · 2024
16. Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi techniquenpj Breast Cancer · 2024
17. Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain AmyloidosisClinicoEconomics and Outcomes Research · 2023
18. Pb2154: The Impact of Disease Severity on the Clinical and Economic Burden of Al AmyloidosisHemaSphere · 2023
19. Pb2135: Treatment Patterns in Patients With Newly Diagnosed Al AmyloidosisHemaSphere · 2023
20. Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 PandemicDermatology and Therapy · 2023